Reaction
Enanthema reporting signals
As of the last recalculation, Enanthema appears in 570 FAERS reports alongside 13 co-occurring drug terms. The strongest observed disproportionality signal is IOHEXOL (PRR 44.8).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Iohexol | 10 | 44.8 | 44.9 |
| Raltegravir | 16 | 36.4 | 36.4 |
| Vemurafenib | 10 | 30.9 | 30.9 |
| Febuxostat Tablets 40 Mg | 8 | 29.1 | 29.1 |
| Febuxostat Tablets 80 Mg | 8 | 29.1 | 29.1 |
| Lamotrigine | 81 | 26.0 | 26.0 |
| Atazanavir | 10 | 25.8 | 25.9 |
| Rifampicin | 7 | 25.6 | 25.6 |
| Ritonavir | 16 | 20.5 | 20.6 |
| Emtricitabine And Tenofovir Disoproxil Fumarate | 17 | 14.0 | 14.0 |
| Apalutamide | 4 | 12.5 | 12.5 |
| Brivaracetam | 3 | 12.2 | 12.2 |
| Durvalumab | 5 | 9.0 | 9.0 |